Orthopaedics was Stryker’s largest segment in fiscal 2015, bringing in $4.22B of $9.95B (42%).
| Statement Business Segments | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 |
|---|---|---|---|---|---|---|---|---|
| United States | — | — | — | — | ||||
| Orthopaedics | — | — | $4.15B | $4.22B | ||||
| Ortho | $3.82B | $3.95B | — | — | ||||
| Reconstructive | — | — | — | — | ||||
| Medsurg | $3.27B | $3.41B | $3.78B | $3.90B | ||||
| Neurotechnology & Spine | $1.57B | $1.66B | $1.74B | $1.83B | ||||
| Europe, Middle East, Africa | — | — | — | — | ||||
| Other European Countries | — | — | — | — | ||||
| Asia Pacific | — | — | — | — | ||||
| Other Foreign Countries | — | — | — | — | ||||
| Ireland | — | — | — | — | ||||
| Total | $8.66B | $9.02B | $9.68B | $9.95B |
Stryker brought in $9.95B from its three segments in fiscal 2015, the year ended December 31, 2015. That was up 2.8% from $9.68B in fiscal 2014. Orthopaedics was the largest at $4.22B (42.5%), ahead of Medsurg at $3.90B (39.2%) and Neurotechnology & Spine at $1.83B (18.4%).
Compared with fiscal 2014, Neurotechnology & Spine grew fastest, up 5.0% to $1.83B. Every segment above 2% of revenue grew.
Stryker began breaking out Orthopaedics in fiscal 2014, when it brought in $4.15B. Stryker stopped reporting Ortho as a separate segment after fiscal 2013, when it brought in $3.95B.
United States was Stryker’s largest region in fiscal 2017, bringing in $9.06B of $12.44B (73%).
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|
| United States | $6.56B | $7.12B | $8.23B | $9.06B | ||
| Europe, Middle East, Africa | $1.37B | $1.27B | $1.44B | $1.57B | ||
| Europe, Middle East, & Africa | — | — | — | — | ||
| Asia Pacific | $1.37B | $1.25B | $1.33B | $1.41B | ||
| Other Foreign Countries | $378.00M | $312.00M | $333.00M | $405.00M | ||
| Total | $9.68B | $9.95B | $11.33B | $12.44B |
Stryker brought in $12.44B from its four regions in fiscal 2017, the year ended December 31, 2017. That was up 9.9% from $11.33B in fiscal 2016. United States was the largest at $9.06B (72.8%), ahead of Europe, Middle East, Africa at $1.57B (12.6%) and Asia Pacific at $1.41B (11.4%). The remaining region, Other Foreign Countries, brought in $405.00M.
Compared with fiscal 2016, Other Foreign Countries grew fastest, up 21.6% to $405.00M. Every region above 2% of revenue grew. From fiscal 2014 to 2017, combined revenue from these regions grew from $9.68B to $12.44B, a compound annual growth rate of 8.8%. United States' share of the total rose from 67.8% to 72.8%.
Stryker (SYK) reports its revenue by statement business segments and by geography. In fiscal 2015, Orthopaedics was its largest segment, bringing in $4.22B (42.5% of the total), followed by Medsurg at $3.90B (39.2%).
Orthopaedics was Stryker's largest segment in fiscal 2015, bringing in $4.22B, or 42.5% of the $9.95B total across its three segments.
United States was Stryker's largest region in fiscal 2017, bringing in $9.06B, or 72.8% of the $12.44B total across its four regions.
Among Stryker's segments that make up at least 2% of revenue, Neurotechnology & Spine grew fastest in fiscal 2015, up 5.0% from $1.74B to $1.83B.
Every figure comes from Stryker's annual financial filings, as reported. Each line keeps the name Stryker gives it, and years follow its fiscal calendar.
Stryker's revenue by statement business segments goes back to fiscal 2008, with figures through fiscal 2015. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.